Clinical Trial Update: Acetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating acetazolamide and spironolactone to increase natriuresis in congestive heart failure has completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)
• Spironolactone (spironolactone)

Snippet

Sponsor: Hasselt University | Conditions: Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2019-03-21